J&J drops 340B rebate model following HRSA pressure

Having trouble viewing this email? See the online version

Monday, September 30, 2024 Monday, September 30, 2024 Insurance J&J drops 340B rebate model following HRSA pressure The agency said Johnson & Johnson faced sanctions because the plan violated 340B drug discount program rules and had not received federal approval. Read More > RELATED ARTICLES HRSA orders J&J to drop controversial 340B rebate model Hospitals seek fines against Johnson & Johnson in 340B battle States build momentum to protect 340B drug discounts - for now Leaders like you are also reading Pediatric mental health startup to pivot, lay off clinicians Brightline is moving from a virtual-only care model to a hybrid model with plans to open in-person clinics.... READ MORE > CommonSpirit's financial gains offset by denials, pay delays The Chicago-based health system saw financial gains driven by higher patient volumes and lower labor costs offset b... READ MORE > Epic fires back at Particle lawsuit Epic said Particle should call on Carequality to publicly release the results of the dispute between the two compan... READ MORE > Texas' Medicaid purge cut millions despite warnings, backlash The decision to buck federal government guidelines was one of many that led to serious repercussions for Texas resi... READ MORE > UNLOCK YOUR ACCESS Discover the latest news, insight & analysis needed to navigate the healthcare industry. VIEW OUR SUBSCRIPTION OFFERS This email was sent to chunduri22.covid@blogger.com Manage My Account | Contact Us   © 2024 Modern Healthcare 130 E. Randolph St., Suite 3200, Chicago, IL 60601 United States Privacy Policy | Terms and Conditions | Unsubscribe